One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1016/j.obmed.2023.100483
Copy DOI Journal: Obesity Medicine |  Publication Date: May 1, 2023 |
 Citations: 1 |
Affiliation: University of Toronto, University Health NetworkTirzepatide, a new class of incretin-based drug for diabetes
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
